Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: AKCA, NERV, NRG, QURE

Published 05/25/2018, 12:22 AM
Updated 07/09/2023, 06:31 AM

Akcea Therapeutics, Inc. (NASDAQ:AKCA) jumped 1.03, or 5%, to 23.60, on 139,924 shares traded on Thursday. I like the overall look of this stock. It had a 3-wave corrective pullback, then a spike-up, a breakaway pullback, and a 2-week flag. This needs to get over 25 to get rolling. If it gets through here, the targets are 29, and then 33. For now, I’ll be watching 25. That should trigger a bigger move, particularly if there is volume.

Minerva Neurosciences, Inc. (NASDAQ:NERV) broke out, we gave you a swing on it, it has followed through nicely, and on Thursday, it got up to 9.00, and closed up 40 cents, or 5%, to 8.95, on 376,879 shares traded. It has more to go. I’m looking for a test of 9.00, and then 10 and 11. Beyond that, 13 1/2 will be the next target.

NRG Energy, Inc. (NYSE:NRG) has been acting well ever since we gave it to you. It consolidated, popped, pulled back in a nice falling flag, and on Thursday it popped out, jumping 1.28, or 5%, to 34.43, on 7.1 million shares. It looks like it might be accelerating. If it is accelerating, I would be looking for something around 37-38. Beyond that, 42-43.

uniQure N.V. (NASDAQ:QURE) popped on Wednesday, pulled back, followed through on Thursday with an inside day, and was still up 1.99, or 6%, to 34.84, on 455,331 shares traded. I think it’s going to get through my 37-dollar target, and run into the 43-44 range.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks on the long side included Axon Enterprise, Inc. (NASDAQ:AAXN), Akcea Therapeutics, Inc. (NASDAQ:AKCA), AXT, Inc. (NASDAQ:AXTI), Baozun Inc. (NASDAQ:BZUN), The Cato Corporation (NYSE:CATO), Cytosorbents Corporation (NASDAQ:CTSO), DocuSign, Inc. (NASDAQ:DOCU), eGain Corporation (NASDAQ:EGAN), Evolus, Inc. (NASDAQ:EOLS), Foundation Medicine, Inc. (NASDAQ:FMI), fosl, Intelsat S.A. (NYSE:I), nLIGHT, Inc. (NASDAQ:LASR), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), Minerva Neurosciences, Inc. (NASDAQ:NERV), NRG Energy, Inc. (NYSE:NRG), Impinj, Inc. (NASDAQ:PI), uniQure N.V. (NASDAQ:QURE), SailPoint Technologies Holdings, Inc. (NYSE:SAIL), Tandem Diabetes Care, Inc. (NASDAQ:TNDM), and Verastem, Inc. (NASDAQ:VSTM).

On the short side, stocks included Bitauto Holdings Limited (NYSE:BITA), Casa Systems, Inc. (NASDAQ:CASA), Edgewell Personal Care Company (NYSE:EPC), Essent Group Ltd. (NYSE:ESNT), Finisar Corporation (NASDAQ:FNSR), Overstock.com, Inc. (NASDAQ:OSTK), The Scotts Miracle-Gro Company (NYSE:SMG), and LendingTree, Inc. (NASDAQ:TREE).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.